Funding transnational collaborative research through joint transnational calls is one of the major objectives of E-Rare. This is the most important and effective joint activity to enhance the cooperation between European scientists working on rare diseases and thus reducing the fragmentation of research in this field. E-Rare launches calls on a yearly basis. The topic and eligibility criteria are specified every year and therefore may vary from one call to the other.

3rd JOINT CALL FOR RESEARCH PROJECTS ON RARE DISEASES (2011)

3rd JOINT CALL FOR RESEARCH PROJECTS ON RARE DISEASES (2011)

GENERAL INFORMATION

The aim of this call was to promote transnational research collaborations on rare diseases.

Nine countries from the European Research Area joined this call: Austria, Belgium, France, Germany, Greece, Israel, Italy, Spain and Turkey.


Transnational research proposals must have covered at least one of the following areas:

  • Definition of new nosological entities, epidemiological studies, genotype/phenotype correlations, natural history of diseases
  • Characterisation of the genetic/molecular basis of specific diseases
  • Pathophysiological and genetic studies of rare diseases
  • Diagnostic and therapeutic research (interventional clinical trials are excluded).

The evaluation process included a two-step selection procedure. In the first step a total of 146 pre-proposals were submitted of which 139 were eligible. After careful examination by the Scientific Evaluation Committee (SEC), 39 pre-proposals were chosen for full submission. Each of the full proposals was then evaluated by at least two additional external experts whose reviews were sent to project coordinators in order to give them the opportunity of studying the assessments and commenting on experts’ arguments and evaluations. Both inputs were taken into account in a second SEC meeting.

Following the second SEC evaluation and ranking of the best projects, 13 consortia with foreseen budget of about 9 Mio € were selected for funding.
The funded projects cover a wide range of rare diseases including hematologic, metabolic, neurologic and dermatologic diseases as well as congenital malformations while adressing potential therapeutic options using state-of-the-art techniques like pluripotent stem cells, gene therapy vectors and customized animal models.

More information on the Aims, the Topics, and the Application and Evaluation procedures can be found in the Call documents (see the "Downlaod documents" section).

To see the list and more information about financed projects click on the button FUNDED PROJECTS.


If you need more information please contact the 3rd Joint Call Secretariat:


Dr. Natalia Martin
e-mail: natalia.martin@agencerecherche.fr
Tel: + 33 1 73 54 81 33

CALL TEXT

The Call text of JTC 2011 is available in the Download documents section of this call.

FUNDED PROJECTS

Year AcronymProject CoordinatorTitle

NATIONAL CONTACT POINTS

If you need more information please contact the 3rd Joint Call Secretariat:

Dr. Natalia Martin
e-mail: natalia.martin@agencerecherche.fr
Tel: + 33 1 73 54 81 33

To find all national contact points for this call please refer to the Call text document that is available in the Download documents section of this call.

E-Rare 2012 - Created by Toussaint Biger